Vox Markets Logo
9th May 2024
06:00

Arecor Therapeutics - Arecor and Medtronic Diabetes collaboration

3rd May 2024
15:44

Arecor Therapeutics - Publication of Full Year Financial Results delayed

29th April 2024
06:00

Arecor Therapeutics - Notice of results

23rd April 2024
06:00

Arecor Therapeutics - BOARD CHANGE

12th March 2024
08:58

Arecor Therapeutics - Arecor and TRx Biosciences research collaboration

12th March 2024
07:00

Arecor Therapeutics - Arecor and TRx Biosciences research collaboration

29th February 2024
07:00

Arecor Therapeutics - Arecor announces launch of Ogluo® in Netherlands

1st February 2024
07:00

Arecor Therapeutics - Year End Trading Update

23rd January 2024
16:58

Arecor Therapeutics - Arecor announces update on INBRX-101

18th January 2024
07:00

Arecor Therapeutics - Arecor granted key European patent

8th January 2024
07:00

Arecor Therapeutics - Expansion of specialty hospital collaboration

3rd January 2024
07:00

Arecor Therapeutics - Appointment of SVP for Tetris Pharma Ltd

4th December 2023
07:00

Arecor Therapeutics - Agreement with global medical products company

29th November 2023
07:00

Arecor Therapeutics - Arecor Continues Collaboration with Lilly

17th November 2023
07:00

Arecor Therapeutics - Product with Arestat technology launched in Europe

Arecor Therapeutics (AREC.L) Share Price & News


Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -M
  • LOW
    -
  • CLOSE
    -
  • SHARES IN ISSUE
    30.63M

Arecor Therapeutics Company Profile

We are ‘advancing today’s therapies to enable healthier lives’ by developing a broad portfolio of therapies for our proprietary pipeline and in partnership with leading pharmaceutical and biotech companies.

Watchlist